MedicalSystem Biotechnology Co., Ltd. (300439) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

MedicalSystem Biotechnology Co., Ltd.

Why is MedicalSystem Biotechnology Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -11.02% and Operating profit at -12.36% over the last 5 years

With a fall in Net Sales of -3.45%, the company declared Very Negative results in Mar 25

The company has declared negative results for the last 2 consecutive quarters
OPERATING CASH FLOW(Y) Lowest at CNY 346.78 MM
ROCE(HY) Lowest at 7.26%
INVENTORY TURNOVER RATIO(HY) Lowest at 3.76%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -7.37% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is MedicalSystem Biotechnology Co., Ltd. for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

MedicalSystem Biotechnology Co., Ltd.

-100.0%

0.47

31.79%

China Shanghai Composite

15.19%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-11.02%

EBIT Growth (5y)

-12.36%

EBIT to Interest (avg)

24.44

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.25

Sales to Capital Employed (avg)

0.65

Tax Ratio

6.81%

Dividend Payout Ratio

20.02%

Pledged Shares

Institutional Holding

ROCE (avg)

9.78%

ROE (avg)

8.27%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.82

EV to EBIT

19.99

EV to EBITDA

5.04

EV to Capital Employed

0.75

EV to Sales

1.03

PEG Ratio

Dividend Yield

2.12%

ROCE (Latest)

3.75%

ROE (Latest)

4.74%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -0.13% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 2.72%

-32What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 346.78 MM

ROCE(HY)

Lowest at 7.26%

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.76%

NET SALES(Q)

At CNY 369.89 MM has Fallen at -14.34%

INTEREST COVERAGE RATIO(Q)

Lowest at 6,385.04

PRE-TAX PROFIT(Q)

At CNY 35.85 MM has Fallen at -46.05%

OPERATING PROFIT(Q)

Lowest at CNY 24.08 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 6.51 %

NET PROFIT(Q)

Lowest at CNY 29.85 MM

EPS(Q)

Lowest at CNY 0.08

Here's what is working for MedicalSystem Biotechnology Co., Ltd.

Debtors Turnover Ratio

Highest at 2.72%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -0.13% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for MedicalSystem Biotechnology Co., Ltd.

Operating Cash Flow

Lowest at CNY 346.78 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

At CNY 369.89 MM has Fallen at -14.34%

over average net sales of the previous four periods of CNY 431.79 MM

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Interest Coverage Ratio

Lowest at 6,385.04

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Pre-Tax Profit

At CNY 35.85 MM has Fallen at -46.05%

over average net sales of the previous four periods of CNY 66.46 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 29.85 MM has Fallen at -53.72%

over average net sales of the previous four periods of CNY 64.5 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Inventory Turnover Ratio

Lowest at 3.76% and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Operating Profit

Lowest at CNY 24.08 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 6.51 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Net Profit

Lowest at CNY 29.85 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

EPS

Lowest at CNY 0.08

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CNY)